Best Practices for Curative-Intent Concurrent Chemoradiation Therapy in Unresectable Stage III NSCLC
Manage episode 250210097 series 1103955
Guest: Kristin Higgins, MD
Concurrent chemoradiation therapy is the recommended treatment for unresectable Stage III NSCLC patients. Dr. Jennifer Caudle is joined by Dr. Kristin Higgins to discuss advances in radiation that optimize the treatment plan and her best practices to help patients receive a full course of curative-intent treatment.
US-32345 Last Updated 12/19